The massive market transformation this month that some on Wall Street called a "once in a decade opportunity" might have just been a one-off technical move because of taxes.Marketsread more
The Pentagon will deploy U.S. forces to the Middle East on the heels of the attack on Saudi Arabian oil facilities, United States Secretary of Defense Mark Esper announced...Defenseread more
CNBC did a deep dive through the most recent Wall Street research to find stocks that analysts say are underappreciated.Marketsread more
Shares of MasterCard are up 46% this year, and 1120% since 2011, getting a boost from the strong U.S. consumer.Investingread more
CNBC sat in on an "empathy training" at Amazon PillPack's Somerville offices, which is part of new hire orientation.Technologyread more
Trade with China is the 'big unknown' for the Federal Reserve as it decides how best to support the U.S. economy, says Council on Foreign Relations Director of International...Futures Nowread more
Lobbying experts said the visit is likely an attempt to be in lawmakers' ears as they consider legislation that would impact Facebook.Technologyread more
Yardeni Research's Edward Yardeni believes the U.S. economy is picking up steam.Trading Nationread more
Iran's audacious drone and cruise missile attack on Saudi Arabia's oil producing facilities has provided a critical test yet for the Trump administration's foreign policy. A...Politicsread more
Chinese trade negotiators suddenly canceled a visit to meet U.S. farmers after they wrapped up trade talks in Washington this week.Marketsread more
(Adds background, detail)
WASHINGTON, Aug 26 (Reuters) - The U.S. Drug Enforcement Administration said on Monday that it will set new guidelines to expand marijuana research and potentially lead to products that could be sold nationwide.
The new guidelines will make it easier to register more qualified growers and increase the variety of marijuana products available for medical and scientific research, the agency said.
That should lead to greater understanding about the effects of marijuana and "potentially aid in the development of safe and effective drug products that may be approved for marketing by the Food and Drug Administration," DEA said in a regulatory filing.
The DEA also said producers of hemp, an industrial form of marijuana that has little psychoactive effect, will no longer have to register with the U.S. government.
Though marijuana is legal for recreational or medical use in 33 states and the District of Columbia, it remains illegal under federal law, and researchers must secure a federal permit if they want to work with the drug.
As the legal market has expanded, DEA says it has faced a growing number of permit applications. (Reporting by Andy Sullivan Editing by Chizu Nomiyama and Marguerita Choy)